41
Participants
Start Date
December 31, 2008
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
DOCETAXEL
50 mg/m² IV as a 1 hour infusion on day 1 for each period of 3 weeks for 3 cycles.
S-1
80mg/m² day 1-14 every 3 weeks for 3 cycles. The curative resection group will receive two oral doses of 40 mg/m²/day for 4 weeks, followed by 2 weeks rest, for 1 year.
OXALIPLATIN
100 mg/m² on day 1 as a two-hour IV infusion for each period of 3 weeks for 3 cycles.
Sanofi-Aventis Administrative Office, Seoul
Lead Sponsor
Sanofi
INDUSTRY